Argentine research team designed a test Ineco in seven minutes you can detect dysfunction of the frontal lobes of the brain that affect memory and the ability to plan or interact, Efe said Thursday its director.
"Front Ineco Screening is a brief tool that, with a demonstrated sensitivity of 96 percent and a very specific, differentiating frontotemporal dementia from Alzheimer's disease.
The test is intended to check the functioning of the brain's frontal lobe, ie the area that is responsible for making decisions, planning, social interaction and memory.
"It is a dementia in which people change the personality, respects no manners, and apathy may have difficulty getting along," he told Efe Facundo Manes, research leader.
The symptoms of this neurodegenerative disease are also disinhibition, materialized with impulsive behaviors, or changes in diet, and tended to sweet foods.
This type of dysfunction, which mainly affects patients between 40 and 65 with Alzheimer's may also occur in young people aged 20 years who do not suffer another kind of pathology.
"The interesting thing about this disease, however, is the cognitive part: memory, language or attention, and it is very difficult for doctors to diagnose, because what changes is the behavior, not the cognitive aspects," the also director of the Institute of Neurosciences, Favaloro Foundation local.
The test "Front Ineco Screening" is a neuropsychological test that seeks to replace the previous controls, which were delayed two hours to discuss patients and high cost of materials needed or highly qualified personnel.
"This test is, however, a brief tool sensitive and specific for the detention of executive dementia that occurs in patients and allows doctors who do not have to implement this battery materials," said Manes.
The test consists of eight sections that control the concentration and retention of patient information.
0 comments:
Post a Comment